Search research articles
Contact Us
Filters
Showing results (71-80 of 180) with videos related to
Page
of 18
Sort By:
The Journal of Urology
|
December 22, 2020
Followup of Men with PI-RADS<sup>TM</sup> 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter.<i>J Urol</i> 2021; <b>205:</b> 748
Vasilis Stavrinides, Francesco Giganti, Clare Allen, et al.
British Journal of Cancer
|
September 9, 2023
REPRESENT recommendations: improving inclusion and trust in cancer early detection research
Frederike Brockhoven, Maya Raphael, Jessica Currier, et al.
Current Oncology (Toronto, Ont.)
|
November 10, 2022
Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer
Nicole Mittmann, Soo Jin Seung, Christina Diong, et al.
The British Journal of Radiology
|
July 8, 2021
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
Francesco Giganti, Clare Allen, Vasilis Stavrinides, et al.
PLOS Digital Health
|
December 15, 2023
Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold
Matthew Barclay, Cristina Renzi, Antonis Antoniou, et al.
NPJ Precision Oncology
|
September 27, 2023
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment
Chiara Herzog, Allison Jones, Iona Evans, et al.
Nature Communications
|
April 2, 2025
Systems epigenetic approach towards non-invasive breast cancer detection
Chiara M S Herzog, Bente Theeuwes, Allison Jones, et al.
Cancer
|
January 4, 2024
Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors
Rikesh Bhatt, Ardo van den Hout, Antonis C Antoniou, et al.
British Journal of Cancer
|
August 21, 2015
Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
Nora Pashayan, Paul Dp Pharoah, Johanna Schleutker, et al.
Preventive Medicine Reports
|
May 24, 2021
Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters
Douglas M Puricelli Perin, Tess Christensen, Andrea Burón, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 180) with videos related to
Sort By:
Page
of 18
The Journal of Urology
|
December 22, 2020
Followup of Men with PI-RADS<sup>TM</sup> 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter.<i>J Urol</i> 2021; <b>205:</b> 748
Vasilis Stavrinides, Francesco Giganti, Clare Allen, et al.
British Journal of Cancer
|
September 9, 2023
REPRESENT recommendations: improving inclusion and trust in cancer early detection research
Frederike Brockhoven, Maya Raphael, Jessica Currier, et al.
Current Oncology (Toronto, Ont.)
|
November 10, 2022
Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer
Nicole Mittmann, Soo Jin Seung, Christina Diong, et al.
The British Journal of Radiology
|
July 8, 2021
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
Francesco Giganti, Clare Allen, Vasilis Stavrinides, et al.
PLOS Digital Health
|
December 15, 2023
Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold
Matthew Barclay, Cristina Renzi, Antonis Antoniou, et al.
NPJ Precision Oncology
|
September 27, 2023
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment
Chiara Herzog, Allison Jones, Iona Evans, et al.
Nature Communications
|
April 2, 2025
Systems epigenetic approach towards non-invasive breast cancer detection
Chiara M S Herzog, Bente Theeuwes, Allison Jones, et al.
Cancer
|
January 4, 2024
Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors
Rikesh Bhatt, Ardo van den Hout, Antonis C Antoniou, et al.
British Journal of Cancer
|
August 21, 2015
Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
Nora Pashayan, Paul Dp Pharoah, Johanna Schleutker, et al.
Preventive Medicine Reports
|
May 24, 2021
Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters
Douglas M Puricelli Perin, Tess Christensen, Andrea Burón, et al.
Page
of 18